The Royal Victoria Eye and Ear Hospital Revenue and Competitors

Dublin City, County Dublin IRE

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • The Royal Victoria Eye and Ear Hospital's estimated annual revenue is currently $7.5M per year.(i)
  • The Royal Victoria Eye and Ear Hospital's estimated revenue per employee is $48,077

Employee Data

  • The Royal Victoria Eye and Ear Hospital has 156 Employees.(i)
  • The Royal Victoria Eye and Ear Hospital grew their employee count by 8% last year.

The Royal Victoria Eye and Ear Hospital's People

NameTitleEmail/Phone
1
ICT Systems ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M1568%N/AN/A
Add Company

What Is The Royal Victoria Eye and Ear Hospital?

A dedicated center of excellence for Opthalmology and ENT care, set in the heart of Dublin city. History. The hospital was established by amalgamating the National Eye Hospital (founded in 1814 by Isaac Ryall) and St. Mark's Ophthalmic Hospital for Diseases of the Eye and Ear (founded by Sir William Wilde in 1844) in 1895. The campaign to do this was spearheaded by ophthalmologist Sir Henry Rosborough Swanzy. Along with the authorisation to merge the hospitals, the Dublin Eye and Ear Hospital Act 1895 provided for expansion of the facilities. A site was purchased on Adelaide Road in 1899 and, once new facilities had been constructed, all patients were transferred from the National Eye Hospital and St. Mark's Hospital on 18 February 1904. Dr. Kathleen Lynn was the first female doctor to work at the hospital when she was appointed in 1910. Lynn went on to establish Saint Ultan's Children's Hospital and became an activist and politician noted for her involvement in the 1916 Easter Rising.

keywords:N/A

N/A

Total Funding

156

Number of Employees

$7.5M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1639%N/A
#2
$38.3M166-19%N/A
#3
$38.3M166-19%N/A
#4
$40.8M20613%N/A